دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Does ‘B’ stand for ‘benefit’? Decoding the B-cell neighborhood in head and neck cancer for predicting therapeutic response to PD-1 inhibitors
doi : 10.1016/j.annonc.2024.01.010
Volume 35, Issue 4, April 2024, Pages 335-337
Centralisation of care improves overall survival for sarcoma patients
doi : 10.1016/j.annonc.2024.01.009
Volume 35, Issue 4, April 2024, Pages 338-339
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
doi : 10.1016/j.annonc.2023.12.011
Volume 35, Issue 4, April 2024, Pages 340-350
Improved nationwide survival of sarcoma patients with a network of reference centers
doi : 10.1016/j.annonc.2024.01.001
Volume 35, Issue 4, April 2024, Pages 351-363
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
doi : 10.1016/j.annonc.2024.01.003
Volume 35, Issue 4, April 2024, Pages 364-380
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040☆
doi : 10.1016/j.annonc.2023.12.008
Volume 35, Issue 4, April 2024, Pages 381-391
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
doi : 10.1016/j.annonc.2024.01.002
Volume 35, Issue 4, April 2024, Pages 392-401
Inflammatory bowel disease and risk of malignant neoplasm in the small bowel
doi : 10.1016/j.annonc.2023.12.012
Volume 35, Issue 4, April 2024, Pages 402-404
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
doi : 10.1016/j.annonc.2023.12.009
Volume 35, Issue 4, April 2024, Pages 404-406
